P01116 (RASK_HUMAN) Homo sapiens (Human)

GTPase KRas UniProtKBInterProSTRINGInteractive Modelling

189 aa; Sequence (Fasta) ; (Isoform 2; ) 24 identical sequences

Molecule Processing
GTPase KRas
GTPase KRas, N-terminally processed

Sequence Features

 5K -> E (in NS3; dbSNP:rs193929331) VAR_065144 dbSNP
 5K -> N (in GASC; found also in a patient with Costello syndrome; exhibits only minor alterations in its in vitro biochemical behavior compared to wild-type protein; dbSNP:rs104894361) VAR_064849 dbSNP
 10G -> GG (in AML; expression in 3T3 cell causes cellular transformation; expression in COS cells activates the Ras-MAPK signaling pathway; lower GTPase activity; faster GDP dissociation rate) VAR_034601
 12G -> A (in a colorectal cancer sample; somatic mutation; dbSNP:rs121913529) VAR_036305 dbSNP
 12G -> C (in lung carcinoma; somatic mutation; dbSNP:rs121913530) VAR_006839 dbSNP
 12G -> D (in GASC, JMML and SFM; somatic mutation; also found in pancreatic carcinoma and lung carcinoma; dbSNP:rs121913529) VAR_016026 dbSNP
 12G -> R (in lung cancer and bladder cancer; somatic mutation; dbSNP:rs121913530) VAR_016027 dbSNP
 12G -> S (in GASC and JMML; also found in lung carcinoma; somatic mutation; dbSNP:rs121913530) VAR_016028 dbSNP
 12G -> V (in GASC; also found in lung carcinoma, pancreatic carcinoma and colon cancer; somatic mutation; it is constitutively activated and stimulates transcription activation of tumor suppressor genes in non-transformed fibroblasts; dbSNP:rs121913529) VAR_006840 dbSNP
 13G -> D (in GASC, JMML and OES; also found in a breast carcinoma cell line; somatic mutation; dbSNP:rs112445441) VAR_016029 dbSNP
 13G -> R (in pylocytic astrocytoma; somatic mutation; increase activation of the Ras pathway; dbSNP:rs121913535) VAR_065145 dbSNP
 14V -> I (in NS3; affects activity and impairs responsiveness to GTPase activating proteins; characterized by a strong increase of both intrinsic and guanine nucleotide exchanged factor-catalyzed nucleotide exchange leading to an increased level of the activated state; dbSNP:rs104894365) VAR_026109 dbSNP
 19L -> F (in OES; somatic mutation) VAR_083261
 22Q -> E (in CFC2; exhibits an increase in intrinsic and guanine nucleotide exchange factor catalyzed nucleotide exchange in combination with an impaired GTPase-activating protein-stimulated GTP hydrolysis but functional in interaction with effectors) VAR_064850
 22Q -> R (in NS3; impairs GTPase-activating protein stimulated GTP hydrolysis with unaffected intrinsic functions and a virtually functional effector interaction; dbSNP:rs727503110) VAR_064851 dbSNP
 34P -> L (in NS3; characterized by a defective GTPase- activating protein sensitivity and a strongly reduced interaction with effectors; dbSNP:rs104894366) VAR_064852 dbSNP
 34P -> Q (in NS3) VAR_064853
 34P -> R (in CFC2; characterized by a defective GTPase-activating protein sensitivity and a strongly reduced interaction with effectors; dbSNP:rs104894366) VAR_026110 dbSNP
 36I -> M (in NS3; dbSNP:rs727503109) VAR_064854 dbSNP
 58T -> I (in NS3; affects activity and impairs responsiveness to GTPase activating proteins; exhibits only minor alterations in its in vitro biochemical behavior compared to wild-type protein; dbSNP:rs104894364) VAR_026111 dbSNP
 59A -> T (in GASC; also found in bladder cancer; somatic mutation; dbSNP:rs121913528) VAR_016030 dbSNP
 60G -> R (in CFC2; characterized by a defective GTPase-activating protein sensitivity and a strongly reduced interaction with effectors; dbSNP:rs104894359) VAR_026112 dbSNP
 60G -> S (in NS3; dbSNP:rs104894359) VAR_065146 dbSNP
 61Q -> H (in lung carcinoma; dbSNP:rs17851045) VAR_006841 dbSNP
 61Q -> R (in a colorectal cancer sample; somatic mutation; dbSNP:rs121913240) VAR_036306 dbSNP
 71Y -> H (in CFC2; dbSNP:rs387907205) VAR_069784 dbSNP
 117K -> N (in a colorectal cancer sample; somatic mutation; dbSNP:rs770248150) VAR_036307 dbSNP
 146A -> T (in OES; somatic mutation; also found in a colorectal cancer sample; dbSNP:rs121913527) VAR_036308 dbSNP
 146A -> V (in OES; somatic mutation) VAR_083262
 147K -> E (in CFC2; dbSNP:rs387907206) VAR_069785 dbSNP
 10-18GTP
 29-35GTP
 59-60GTP
 116-119GTP
 5-164Small GTPase
IPR001806PF00071

Sequence Alignments

GTPase KRas, N-terminally processed 2-186; PRO_0000326480

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
NMR data-driven model of KRas-GMPPNP:RBD-CRD complex tethered to a nanodisc (state B) Heteromer
P02647; P04049;
64×PCW; 16×17F;GNP;MG;ZN;6ptw 1-186
NMR data-driven model of GTPase KRas-GMPPNP:Cmpd2 complex tethered to a nanodisc Heteromer
P02647;
64×PCW; 16×17F;GNP;MG;EWS;6cc9 1-186
NMR data-driven model of KRas-GMPPNP:RBD-CRD complex tethered to a nanodisc (state A) Heteromer
P02647; P04049;
64×PCW; 16×17F;GNP;MG;ZN;6pts 1-186
NMR data-driven model of GTPase KRas-GMPPNP:Cmpd2 complex tethered to a nanodisc Heteromer
P02647;
64×PCW; 16×17F;GNP;MG;EWS;6ccx 1-186
NMR data-driven model of GTPase KRas-GMPPNP tethered to a nanodisc (E3 state) Heteromer
P02647;
64×PCW; 16×17F;GNP;MG;6cch 1-186
Crystal structure of farnesylated and methylated kras4b in complex with PDE-delta (crystal form II … Heteromer
O43924;
FAR;GDP;EDO;5tar 2-186
Crystal structure of full-length farnesylated and methylated KRAS4b in complex with PDE-delta (crys… Heteromer
O43924;
FAR;GDP;EDO;5tb5 2-186
NMR-driven structure of KRAS4B-GDP homodimer on a lipid bilayer nanodisc Heteromer
P02647;
64×PCW; 16×17F;GDP;MG;6w4f 2-185
NMR-driven structure of KRAS4B-GTP homodimer on a lipid bilayer nanodisc Heteromer
P02647;
64×PCW; 16×17F;GSP;MG;6w4e 2-185
Crystal structure of human K-Ras G12D Mutant in complex with GDP and Cyclic Inhibitory Peptide Heteromer
GDP;EDO;5xco 1-169
Crystal structure of G13D-KRAS (GMPPNP-bound) in complex with GAP-related domain (GRD) of neurofibr… Heteromer
P21359;
GNP;MG;CL;MES;6ob3 1-169
RAS GUANINE EXCHANGE FACTOR SOS1 (REM-CDC25) IN COMPLEX WITH KRAS(G12C) AND FRAGMENT SCREENING HIT … Heteromer
Q07889;
GOL;BPW;6epo 1-169
Ras guanine exchange factor SOS1 (Rem-cdc25) in complex with KRAS(G12C) and fragment screening hit … Heteromer
Q07889;
GOL;BQ2;DMS;6epn 1-169
Ras guanine nucleotide exchange factor SOS1 (Rem-cdc25) in complex with KRAS(G12C) and fragment scr… Heteromer
Q07889;
GOL;BQ5;6epm 1-169
Ras guanine exchange factor SOS1 (Rem-cdc25) in complex with KRAS(G12C) Heteromer
Q07889;
GOL;6epl 1-169
Crystal structure of wild-type KRAS (GMPPNP-bound) in complex with GAP-related domain (GRD) of neur… Heteromer
P21359;
GOL;GNP;MG;IMD;CL;6ob2 1-169
RAS GUANINE EXCHANGE FACTOR SOS1 (REM-CDC25) IN COMPLEX WITH KRAS(G12C) AND FRAGMENT SCREENING HIT … Heteromer
Q07889;
GOL;BOQ;6epp 1-168
Crystal structure of Q61L KRAS(GMPPNP)-NF1(GRD)-SPRED1(EVH1) complex Heteromer
P21359; Q7Z699;
FMT;GNP;MG;ZN;6v6f 1-168
Crystal structure of KRAS(GMPPNP)-NF1(GRD)-SPRED1 complex Heteromer
P21359; Q7Z699;
FMT;GNP;MG;ZN;6v65 1-168
Human KRAS in complex with darpin K19 Heteromer
SO4;6h47 1-166
KRas G12V, bound to GppNHp and miniprotein 225-15a/b Heteromer
GNP;MG;PG4;SO4;5wlb 1-166
KRasG12C ligand complex Heteromer
A0A1S2ZE25;
MG;GDP;MKW;6t5u 1-166
Affimer K6 - KRAS protein complex Heteromer
GDP;MG;6yr8 1-166
Affimer K3 - KRAS protein complex Heteromer
GDP;MG;6yxw 2-167
KRas G12V, bound to GDP and miniprotein 225-11(A30R) Heteromer
GDP;MG;CA;5whb 1-166
K-RasG12D(GNP)/R11.1.6 complex Heteromer
GNP;MG;CL;CA;CD;5ufq 1-166
Human KRAS in complex with darpin K13 Heteromer
GDP;SO4;6h46 1-166
Wild-type K-Ras(GNP)/R11.1.6 complex Heteromer
GNP;CA;CD;CL;MG;CO;5ufe 1-166
KRas G12V/D38P, bound to GppNHp and miniprotein 225-11 Heteromer
GNP;CA;MG;5whe 2-166
KRas G12V, bound to GDP and miniprotein 225-11 Heteromer
MG;GDP;CA;5wha 2-166
Crystal structure of human RAS in complex with darpin K27 Heteromer
GDP;MG;5mlb 1-165
Human KRAS in complex with darpin K27 Heteromer
GDP;MG;5o2s 1-165
KRas G12V, bound to GppNHp and miniprotein 225-11(A30R) Heteromer
GNP;MG;SO4;5wpm 1-164
Crystal structure of human RAS in complex with darpin K55 Heteromer
MG;GSP;SO4;5mla 1-164
Human KRAS in complex with darpin K27 Heteromer
MG;GSP;SO4;5o2t 1-164
Structure of HLA-A2:01 with peptide MM96 Heteromer
A0A140T913; P61769;
GOL;SO4;NA;6o53 5-14
Crystal structure of HLA-C05 in complex with a tumor mut10m peptide Heteromer
P10321; P61769;
6jto 10-19
Crystal structure of HLA-C08 in complex with a tumor mut10m peptide Heteromer
C1K0Y1; P61769;
6jtn 10-19
Structure of HLA-A2:01 with peptide MM90 Heteromer
A0A140T913; P61769;
GOL;NA;6o51 6-14
Crystal structure of HLA-C08 in complex with a tumor mut9m peptide Heteromer
C1K0Y1; P61769;
6jtp 10-18
Structure of HLA-A2:01 with peptide MM92 Heteromer
A0A140T913; P61769;
GOL;NA;SO4;6o4z 5-12
Structure of HLA-A2:01 with peptide MM91 Heteromer
A0A140T913; P61769;
GOL;NA;6o4y 7-14
Discovery of small molecules binding to KRAS via high affinity antibody fragment competition method.homo-6-mer GNP;9RK;PEG;MG;CIT;5oco 1-169
Antibody derived (Abd-4) small molecule binding to KRAS.homo-6-mer MG;GNP;D2Z;6fa1 1-169
KRAS-169 Q61H GPPNHPhomo-6-mer GNP;MG;CIT;6gog 1-169
Antibody derived (Abd-8) small molecule binding to KRAS.homo-6-mer MG;GNP;CVK;6f76 1-169
Discovery of small molecules binding to KRAS via high affinity antibody fragment competition method.homo-6-mer GNP;9R5;PEG;MG;DMS;5oct 1-168
Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12Chomo-3-mer SO4;GDP;21F;4lyh 1-169
Crystal Structure of small molecule vinylsulfonamide 8 covalently bound to K-Ras G12Chomo-3-mer GDP;21C;4lyf 1-167
Second-site screening of K-Ras in the presence of covalently attached first-site ligandshomo-2-mer GDP;MG;2XR;4pzy 1-169
Crystal Structure of small molecule disulfide 6 bound to K-Ras G12Chomo-2-mer CA;20G;GDP;4luc 1-168
Crystal structure of KRAS A146T-GDP demonstrating open switch 1 conformationhomo-2-mer GDP;6bof 2-169
Structure of Mg-free KRAS4b (2-169) bound to GDP with the switch-I in fully open conformationhomo-2-mer GDP;6m9w 2-169
Crystal Structure of small molecule disulfide 4 covalently bound to K-Ras G12Chomo-2-mer CA;20H;GDP;4lv6 1-168
Crystal Structure of KRAS-G12D in Complex with Natural Product-Like Compound 9bhomo-2-mer GCP;MG;JJQ;6quw 1-167
Crystal Structure of KRAS-G12D in complex with GMP-PCP and compound 15Rhomo-2-mer GCP;MG;JJN;6quv 1-167
Crystal Structure of KRAS-G12D in Complex with Natural Product-Like Compound 15homo-2-mer GCP;MG;EDO;JJN;6qux 1-167
Crystal structure of small molecule aziridine 3 covalently bound to K-Ras G12Chomo-2-mer GDP;CA;8YA;GOL;5v6v 2-168
Crystal structure of KRas G12V/D38P, bound to GDPhomo-2-mer GDP;5whd 1-166
Crystal Structure of K-Ras G12C (cysteine-light), GDP-boundhomo-2-mer MG;GDP;4lrw 2-167
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchang…monomer GDP;MG;BZI;4dsu 2-181
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchang…monomer GSP;MG;BEN;GOL;4dso 2-181
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchang…monomer GCP;MG;EDO;4dsn 2-181
Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchang…monomer 9LI;GCP;MG;GOL;EDO;DMS;ACT;4dst 2-181
Discovery of small molecules binding to KRAS via high affinity antibody fragment competition method.monomer MG;GNP;9R5;GOL;PEG;5ocg 2-173
KRAS full length wild-type GPPNHPmonomer MG;GNP;GOL;6god 2-173
KRAS full length G12D GPPNHPmonomer MG;GNP;6gof 2-173
Crystal Structure of a GDP-bound G12R Oncogenic Mutant of Human GTPase KRasmonomer GDP;MG;4ql3 1-169
Crystal Structure of a GDP-bound G12C Oncogenic Mutant of Human GTPase KRasmonomer GDP;MG;4ldj 1-169
X-RAY STRUCTURE OF HUMAN K-RAS G12C IN COMPLEX WITH COVALENT ISOQUINOLINONE INHIBITOR (COMPOUND 17)monomer GDP;MG;MZN;6tan 1-169
Second-site screening of K-Ras in the presence of covalently attached first-site ligandsmonomer GDP;MG;2XE;4q03 1-169
Crystal Structure of GDP-bound Human KRasmonomer GDP;MG;4obe 1-169
KRasG12C ligand complexmonomer MG;GDP;MKZ;6t5v 1-169
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activationmonomer GDP;MG;0QX;4epv 1-169
KRasG12C ligand complexmonomer MG;GDP;O7K;SO4;6t5b 1-169
Crystal Structure of small molecule ARS-1620 covalently bound to K-Ras G12Cmonomer CA;91S;GOL;GDP;5v9u 1-169
Second-site screening of K-Ras in the presence of covalently attached first-site ligandsmonomer GDP;MG;2XO;4pzz 1-169
Crystal structure of wild-type KRAS bound to GDP and Mg (Space group C2)monomer GDP;MG;6mbt 1-169
Crystal Structure of Small Molecule Disulfide 2C07 Bound to K-Ras Cys Light M72C GDPmonomer MG;GDP;92V;5vbm 1-169
GDP-bound KRAS P34R mutantmonomer GDP;MG;6ms9 1-169
Crystal structure of human KRAS G12C covalently bound to a quinazolinone inhibitormonomer GDP;CA;OHY;6pgp 1-169
KRAS mutant-A59G in GDP-boundmonomer MG;GDP;6ase 1-169
Crystal structure of human KRAS G12A mutant in complex with GTPmonomer GTP;MG;5vpi 1-169
X-RAY STRUCTURE OF HUMAN K-RAS G12C IN COMPLEX WITH COVALENT ISOQUINOLINONE INHIBITOR (COMPOUND 3)monomer GDP;MG;MZQ;6tam 1-169
Crystal Structure of human KRAS G12C covalently bound to AMG 510monomer MG;GDP;MOV;6oim 1-169
Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI739monomer MG;GDP;94F;EDO;5yy1 1-169
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activationmonomer GDP;MG;0QV;4epw 1-169
Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI484monomer MG;GDP;94C;EDO;5yxz 1-169
Crystal structure of small molecule acrylamide 1 covalently bound to K-Ras G12Cmonomer GDP;MG;8YD;5v6s 1-169
Crystal structure of human KRAS G12A mutant in complex with GDPmonomer GDP;MG;PGE;NA;5vp7 1-169
Second-site screening of K-Ras in the presence of covalently attached first-site ligandsmonomer GDP;MG;2XG;4q02 1-169
Tetrahydropyridopyrimidines as Covalent Inhibitors of KRAS-G12Cmonomer GDP;MG;K9J;6n2k 1-169
Crystal Structure of compound 10 covalently bound to K-Ras G12Cmonomer GDP;MG;BQD;GOL;6ark 1-169
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activationmonomer GDP;MG;0QR;4epx 1-169
Crystal structure of human WT-KRAS in complex with GDPmonomer GDP;MG;5w22 1-169
Crystal structure of human KRAS Q61A mutant in complex with GDPmonomer GDP;MG;5vq1 1-169
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activationmonomer GDP;MG;0QY;4epy 1-169
Crystal structure of human KRAS G12D mutant in complex with GDPmonomer GDP;MG;GOL;5us4 1-169
Crystal structure of human KRAS G12A mutant in complex with GTP-gamma-Smonomer MG;GSP;5vpz 1-169
Crystal Structure of a G12C Oncogenic Variant of Human KRas Bound to a Novel GDP Competitive Covale…monomer MG;Y9Z;4nmm 1-169
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the…monomer GDP;MG;M1X;6ut0 1-169
Crystal structure of human KRAS G12A mutant in complex with GppNHpmonomer MG;9GM;5vpy 1-169
Crystal structure of human KRAS A59G mutant in complex with GCPmonomer GCP;6bp1 1-169
Antibody derived (Abd-7) small molecule binding to KRAS.monomer MG;GNP;D1W;6fa4 1-169
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the…monomer GDP;MG;QH4;6usz 1-169
Structural basis of impaired hydrolysis in KRAS Q61H mutantmonomer GTP;MG;6mnx 1-169
Crystal structure of human KRAS G12A mutant in complex with GDP (EDTA soaked)monomer MG;GDP;5vq0 1-169
The HADDOCK structure model of GDP KRas in complex with its allosteric inhibitor E22monomer GDP;MG;QPD;6v5l 1-169
Crystal Structure of small molecule ARS-917 covalently bound to K-Ras G12Cmonomer CA;8ZG;GOL;GDP;6b0y 1-168
Crystal structure of wild-type KRAS (1-169) bound to GDP and Mg (Space group P3)monomer MG;GDP;GOL;6mbu 1-168
Crystal Structure of small molecule vinylsulfonamide 15 covalently bound to K-Ras G12Cmonomer GDP;4m1y 1-168
Crystal structure of GMPPNP-bound G12R mutant of human KRAS4bmonomer MG;GNP;6cu6 1-168
Crystal structure of human KRAS G12V mutant in complex with GDPmonomer MG;GDP;5uqw 1-168
Crystal Structure of small molecule vinylsulfonamide covalently bound to K-Ras G12Cmonomer MG;21R;GDP;4m1w 1-168
KRAS full length G12V GPPNHPmonomer MG;GNP;6goe 2-169
Crystal structure of KRAS V14I-GDP demonstrating disorder switch 1 conformation - Form 2monomer GDP;6mqn 1-168
Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitormonomer CA;GDP;O5S;6p8z 1-168
Crystal Structure of small molecule vinylsulfonamide 14 covalently bound to K-Ras G12Cmonomer GDP;4m1t 1-168
Tetrahydropyridopyrimidines as Covalent Inhibitors of KRAS-G12Cmonomer GDP;MG;K9M;6n2j 2-169
Crystal Structure of human KRAS G12D mutant in complex with GDPNPmonomer MG;GNP;5usj 1-168
Crystal structure of human WT-KRAS in complex with GTPmonomer GTP;MG;5vq2 1-168
Crystal structure of human WT-KRAS in complex with GTP-gamma-Smonomer GSP;MG;5vq6 1-168
Crystal Structure of small molecule acrylamide 16 covalently bound to K-Ras G12Cmonomer MG;GDP;4m22 1-168
Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor.monomer CA;GDP;O67;6p8w 1-168
KRAS P34R mutant structure in complex with GTP analoguemonomer GNP;MG;6mta 1-168
Crystal structure of human WT-KRAS in complex with GDP (EDTA soaked)monomer GDP;MG;5vq8 1-168
Crystal structure of N-acetylated KRAS (2-169) bound to GDP and Mgmonomer MG;GDP;ACE;6p0z 2-168
Crystal Structure of a GDP-bound G13D Oncogenic Mutant of Human GTPase KRasmonomer GDP;MG;4tqa 1-167
Crystal Structure of small molecule ARS-107 covalently bound to K-Ras G12Cmonomer CA;C8G;GDP;6b0v 1-167
Crystal Structure of small molecule ARS-853 covalently bound to K-Ras G12Cmonomer MG;GOL;5UT;GLY;GDP;5f2e 1-167
Crystal Structure of KRAS-G12D in complex with GMP-PCPmonomer GCP;MG;6quu 1-167
Crystal Structure of a GDP-bound G12V Oncogenic Mutant of Human GTPase KRasmonomer GDP;MG;4tq9 1-167
CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH 15monomer GCP;MG;F0N;6gj5 1-167
Crystal structure of KRAS V14I-GDP demonstrating open switch 1 conformation - Form 1monomer GDP;6mqg 3-169
Crystal Structure of K-Ras G12C, GDP-boundmonomer GDP;MG;NA;4l8g 1-167
Crystal Structure of small molecule vinylsulfonamide 13 covalently bound to K-Ras G12Cmonomer GDP;4m1s 1-167
KRAS G12C inhibitormonomer GDP;MG;91G;5v9o 1-167
Crystal Structure of small molecule vinylsulfonamide 7 covalently bound to K-Ras G12Cmonomer GDP;4m1o 1-167
Crystal structure of human KRAS G12C covalently bound to a phthalazine inhibitormonomer MG;GDP;OJ1;6pgo 1-167
KRAS-169 Q61H GPPNHP + PPIN-1monomer GNP;MG;CIT;F6E;6gom 1-167
CRYSTAL STRUCTURE OF KRAS-G12D(C118S) IN COMPLEX WITH BI-2852 AND GDPmonomer MG;GDP;F0K;SO4;6zl5 1-167
CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH BI 2852monomer F0K;MG;GCP;6gj8 1-167
KRAS-169 Q61H GPPNHP + PPIN-2monomer GNP;MG;CIT;6gqt 1-167
CRYSTAL STRUCTURE OF KRAS-G12D IN COMPLEX WITH COMPOUND 13 AND GCPmonomer GCP;MG;6zli 1-167
Crystal structure of GDP-bound KRAS with ten residues long internal tandem duplication in the switc…monomer GDP;MG;SO4;6pq3 1-167
CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH 18monomer MG;NO3;GCP;EZZ;6gj6 1-167
Antibody derived (Abd-6) small molecule binding to KRAS.monomer MG;GNP;D1Z;6fa3 1-167
Crystal structure of human KRAS P34R mutant in complex with GNP and Phosphatemonomer GNP;MG;PO4;6o46 1-167
Crystal Structure of small molecule acrylamide 11 covalently bound to K-Ras G12Cmonomer GDP;4m21 1-167
KRAS G12C in bound to quinazoline based switch II pocket (SWIIP) bindermonomer GDP;MG;91D;5v9l 1-167
Crystal Structure of a GDP-bound Q61L Oncogenic Mutant of Human GT- Pase KRasmonomer GDP;MG;4wa7 1-167
Crystal structure of human KRAS P34R mutant in complex with GNPmonomer MG;PO4;GNP;6o36 1-167
KRAS-169 Q61H GPPNHP + CH-2monomer MG;GNP;F8K;6gqx 1-167
KRAS G12C in bound to quinazoline based switch II pocket (SWIIP) bindermonomer GDP;MG;8ZG;5v71 1-167
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the…monomer GDP;MG;M1R;6usx 1-167
Human K-Ras (Q61H) in complex with a GTP analoguemonomer MG;GNP;UNX;3gft 1-167
KRAS mutant-D33E in GDP-boundmonomer GDP;MG;6asa 1-167
Antibody derived (Abd-5) small molecule binding to KRAS.monomer MG;GNP;D2W;6fa2 1-167
Covalent GTP-competitive inhibitors of KRAS G12C: Guanosine bisphosphonate Analogsmonomer 6ZD;5kyk 1-167
KRAS-169 Q61H GPPNHP + CH-3monomer MG;GNP;F8Q;6gqy 1-167
KRAS-169 Q61H GPPNHP + CH-1monomer MG;GNP;F8T;6gqw 1-167
Second-site screening of K-Ras in the presence of covalently attached first-site ligandsmonomer GDP;MG;2XH;4q01 1-166
Crystal Structure of K-Ras WT, GDP-boundmonomer GDP;CA;NA;4lpk 1-166
CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH 22monomer MG;GCP;F0B;6gj7 1-166
Wild-type K-Ras(GCP) pH 6.5monomer GDP;MG;GOL;5uk9 1-166
Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12C, alternative …monomer MG;21F;GDP;4lyj 2-167
KRAS G13D bound to GDP (K13GDP)monomer GDP;CA;NA;6e6g 1-166
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-mediated Activationmonomer GDP;MG;0QW;4ept 1-166
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation.monomer GDP;MG;4epr 1-166
Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor.monomer CA;GDP;O5V;6p8x 2-167
Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor.monomer MG;GDP;O5Y;6p8y 1-166
KRAS G13D bound to GppNHp (K13GNP)monomer GNP;MG;6e6f 1-166
Crystal structure of Mg-free wild-type KRAS (2-166) bound to GMPPNP in the state 1 conformationmonomer NA;EDO;GNP;6mbq 2-166
Oligo-stateLigandsQMEANTemplateRangeSeq id (%)DownloadAssess
monomer 9LI;MG;0.274dst.1.A2-181
88.77

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomer9LI;MG;0.044dst.1.A2-180
99.47